Stock Expert AI

Content generated by AI editorial engine. Editorially supervised by Sedat ANAK.

The Procter & Gamble Company
PG - NYSE - $146.99 ▲ +%0.13
-
Earnings Fri 23 Oct

Procter opens the
books on Friday evening.

4 analysts' median target is $162[FMP target], stock is $147, +10.2% vs the analyst consensus median. After Q3 +1.4% EPS beat[FMP earnings], the stock moved -1.5%.

summary below
Quick Take - in 40 seconds
B+
HOLD Council 2/6 - Moonshot 43

B+ = MoonshotScore 43[multi-pillar formula] + Council 2/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Quick Answer

The Procter & Gamble Company (PG) Q1 consensus: revenue $22.7B[FMP est], EPS $1.90[FMP est]. 6 consecutive quarters of beat[FMP earnings].

$1.90 EPS Estimate Last year $1.99 - -5% YoY YoY
4% Skin and Personal Care Guidance Previous quarter was 3%
6 Beat Streak Expectations beaten consecutively for the last 6 quarters

Q3 EPS +1.4% beat[FMP] but the stock -1.5% D+1[FMP D+1].

Watchlist

5 metrics stand out this quarter.

%3 Investor Focus

Dividend Increase Shareholder Returns

dividend_increase_shareholder_returns

P&G increased its dividend by 3%, continuing its commitment to return cash to shareholders, and plans to return approximately $15 billion in cash to shareowners in FY26.

"Earlier this month, we announced a 3% increase in our dividend, continuing our commitment to return cash to shareowners, and this marks the seventh consecutive annual dividend increase and the 136 consecutive year P&G has paid a dividend. ... We expect to pay around $10 billion in dividends and to repurchase approximately $5 billion of common stock, combined a plan to return roughly $15 billion of cash to shareowners at fiscal '26."

- Andre Schulten - Q3 FY26 Earnings Call - April 24, 2026
$150 million Investor Focus

Middle East Conflict Cost Impact

middle_east_conflict_cost_impact

An additional after-tax cost of approximately $150 million is expected for FY26 due to commodity, feedstock, and logistics disruptions from the Middle East conflict, with most of this impact occurring in the fourth quarter.

"We now expect a headwind of approximately $150 million after tax for the fiscal from a combination of commodity-linked cost inflation, feedstock exposures and logistics disruptions resulting from the conflict in the Middle East. Almost all of these increased costs will be in the fourth -- fiscal fourth quarter."

- Andre Schulten - Q3 FY26 Earnings Call - April 24, 2026
- Risk Indicator

Capex Increase

capex_increase

P&G expects an increase in capital spending to add capacity in several categories and to incur cash costs from restructuring work.

"This includes an increase in capital spending as we add capacity in several categories and as we incur the cash costs from the restructuring work."

- Andre Schulten - Q3 FY26 Earnings Call - April 24, 2026
- Expectation / Guide

Fy26 Eps Guidance Lower End

fy26_eps_guidance_lower_end

The company revised its core EPS outlook for FY26 towards the lower end of the guidance range due to geopolitical dynamics and increased costs.

"Given all the above, we now expect full year EPS results to be towards the lower end of the guidance range."

- Andre Schulten - Q3 FY26 Earnings Call - April 24, 2026
- Investor Focus

Strategy Superiority Productivity

strategy_superiority_productivity

The company continues to focus on product superiority, innovation, demand creation, and productivity improvements to gain a competitive advantage in challenging market conditions.

"As we move forward, we remain committed to the integrated growth strategy, a portfolio of daily use products and categories where performance matters. In these performance-driven categories, we must deliver irresistibly superior products across the product itself, the package, the brand communication, retail execution and value. We continue to drive productivity with multiyear visibility to fund innovation and demand creation and to mitigate cost headwinds."

- Andre Schulten - Q3 FY26 Earnings Call - April 24, 2026

Stock Expert AI - Methodology

Do our scoring pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 2 / 6 Bullish

6 investor frameworks. 2 bullish (Ray Dalio, Buffett), 1 bearish (Ken Griffin), 3 neutral (Jim Simons, Klarman, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +10.2%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 49
Klarman value - target upside +10.2%
Buffett quality - ROE score 5/5
Munger valuation - target upside +10.2%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
48.9 RSI 48.9 balanced, 50d below
MACD
-0.40 price below 50d - resistance dominant
50d MA
$148 stock 0.4% below - short-term resistance
200d MA
$148 stock 0.7% below - long-term pressure
Volume (10d)
-38% decrease - low participation
Resistance
$162
Analyst median target - upgrade trigger if broken
Current
$147
Pre-earnings position
Support
$126
Invalidation - close below this is a technical breakdown
Pattern
Range
$126-$162 band - earnings breakout/breakdown trigger

Past Performance

The's last 8 quarters: 6 consecutive beats.

BEAT
Q1 FY26
$1.99 vs $1.90 est - -0.5%
BEAT
Q2 FY26
$1.88 vs $1.86 est - +0.1%
BEAT
Q3 FY26
$1.59 vs $1.56 est - +0.1%
BEAT
Q4 FY26
$1.43 vs $1.41 est - -1.5%

Q3 (April 24, 2026): EPS $1.43 vs $1.41 est[FMP], +1.4% beat. D+1 movement: -1.5%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $1.84 (no guidance)

Q3: EPS $1.43 vs $1.41 beat[FMP], stock -1.5% D+1[FMP]. Andre Schulten Q3 transcript: "We continue to expect organic sales growth of in line to 4%."[Andre Schulten].

"We continue to expect organic sales growth of in line to 4%."

- Andre Schulten, CFO - Q3 FY26 Earnings Call - April 24, 2026
Backlog concentration

No RPO/backlog concentration disclosed in Q3 earnings call.

CapEx shock

Q3 CapEx $1.0B[FMP cashflow]. Q3 op margin 18.6%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.

"This includes an increase in capital spending as we add capacity in several categories and as we incur the cash costs from the restructuring work."

- Andre Schulten, CFO - Q3 FY26 Earnings Call - April 24, 2026
Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q1 EPS > $1.90 + CapEx discipline
Threshold: EPS > $1.90[FMP est].
Target: Break above median target $162[FMP target]; high target $172[FMP] upper bound.
Scenario B - In-Line
EPS approx $1.90 + CapEx < $1.0B
Threshold: EPS approx $1.90[FMP est], Q1 CapEx < $1.0B[FMP].
Target: Consolidation in the band between current $147[FMP] and median $162[FMP].
Scenario C - Miss
EPS < $1.84 or CapEx >= $1.0B
Threshold: EPS < $1.84[FMP estx0.97].
Target: Current $147 below SMA200 $148[FMP], if rejection continues, $126[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 4 analysts say?

Wall Street Consensus
$162
12-month median target price (+10.2% gap to the analyst consensus median)
14
BUY
11
HOLD
0
SELL
Risk Management
$126
Invalidation level - critical support threshold
$148 - 50-day MA (below, -0.4%)
$148 - 200-day MA (below, -0.7%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - PG Q1 FY27
B+

You read it in 5 minutes. When the numbers come out on Friday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Friday evening. The framework is ready on this page: Q1 EPS threshold $1.90[FMP], CapEx threshold "below $1.0B". Two anchors, three scenarios.

Comparison Stock Expert AI is free today — no credit card.

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI is free today — no credit card. Council 7-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Oct 23, 2026EARNINGSQ1 FY27 results (after market close) + earnings call
Oct 24, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Dec 7, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Jan 23, 2027EARNINGSQ2 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the PG earnings preview cover?

This The Procter & Gamble Company (PG) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in PG earnings?

The Procter & Gamble Company (PG): Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.

Where do the numbers on this page come from?

The Procter & Gamble Company (PG): Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.

Is this a buy or sell recommendation?

The Procter & Gamble Company (PG): No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.

More earnings, decoded